Advertisement

Topics

Pharmaron Acquires Majority Stake in SNBL CPC

10:00 EST 28 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Acquisition expands Pharmaron’s integrated offerings to clinical development phase Pharmaron, a fully integrated contract research organization offering R&D services to the life sciences industry, today announced that ...

Other Sources for this Article

Pharmaron
Ashok Tehim, +1 201-312-5754
Senior VP, Strategy
ashok.tehim@pharmaron.com
or
Ellen Cabral, +1 617-901-2216
Director, Global Marketing
ellen.cabral@pharmaron.com

NEXT ARTICLE

More From BioPortfolio on "Pharmaron Acquires Majority Stake in SNBL CPC"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...